Real-World Data Has Real Impact On Clinical Research

In a recent discussion at Norstella, experts examined the critical role of real-world data (RWD) in clinical research, distinguishing it from real-world evidence (RWE). Each expert covered varying aspects of RWD. Dr. Shrinal Patel clarified that RWD encompasses raw data derived from healthcare interactions, including unstructured information from medical records and lab results, which necessitates careful cleaning and mapping for effective application. Ilan Behm underscored the significance of RWD collection during patient encounters, emphasizing its potential to uncover trends that enhance patient access to therapies and clinical trials. Alison Perry highlighted how Citeline's datasets improve visibility into clinical trial performance and patient trajectories by integrating RWD with patient-level data for a holistic understanding.

Norstella’s RWD datasets readily link to Citeline's Trialtrove datasets, enhancing our ability to bring together data from varying health systems. The panel of experts in this discussion collectively recognized that the full potential of RWD to optimize patient treatment pathways remains largely untapped and expressed a commitment to responsibly harnessing this data to enhance healthcare outcomes. Read the full piece to learn more about the transformative capabilities of RWD in shaping the future of clinical research and patient care.